Albumin Market will Generate Revenue of $10,305 million by 2023
Albumin is globular protein found in liquid component of blood called plasma. It is most abundant protein in plasma constituting around 50% of the total protein in the blood. It plays a vital role in maintaining proper oncotic pressure of blood and transporting hormones, fatty acids, and other compounds throughout the body. It is derived from blood plasma on fractionation, and is widely used to clinically to treat variety of diseases. Different types of albumin are used clinically. These include human serum albumin, bovine serum albumin, and recombinant albumin.
Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/2583
The factors that drive the growth of the albumin market include increase in prevalence of life-threatening diseases and conditions namely surgical procedures, liver diseases, trauma and burns cases, and others. Moreover, rise in awareness about recombinant albumin products, upsurge in demand for albumin products, and growth in non-therapeutic application of albumin also fuel the growth of the market. However, stringent governmental regulations and reforms, and risk of side effects associated after using albumin products impede the market growth. Conversely, the development of cost-effective therapeutic along with large production of albumin and presence of untapped market in emerging economies are expected to provide lucrative growth opportunities for the market.
The human serum albumin segment accounted for the largest share in 2016, owing to high usage as blood volumizer and applicability for treating variety of diseases and improved human serum albumin production due to the emergence of advanced technologies. However, the recombinant albumin segment is expected to grow at the high CAGR from 2017 to 2023.
The utilization rate of albumin for therapeutics is high owing to rise in prevalence of trauma and cases of burns as well as increase in the number of surgical procedures. However, drug formulation and vaccines segment is expected to grow at a high CAGR during the forecast period.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2583
Key Findings of the Albumin Market:
o The bovine serum albumin segment accounted for nearly one-eighth share of the global albumin market in 2016.
o The recombinant albumin segment is expected to grow at highest CAGR from 2017 to 2023.
o The component of media segment accounted for around one-fifth share of the global market in 2016.
o Europe accounted for around one-third share of the global market in 2016.
o LAMEA is expected to provide lucrative market growth opportunities from 2017 to 2023.
North America was the leading revenue contributor to the global albumin market in 2016, and is expected to dominate the market during the forecast period. This is attributed to the early approval of albumin products and high adoption of recombinant albumin in this region. However, Asia-Pacific is expected to grow at the highest CAGR during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness toward albumin products.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Albumin Market will Generate Revenue of $10,305 million by 2023 here
News-ID: 2038905 • Views: 164
More Releases from Allied Market Research
Ultrasonic Air Bubble Detectors Market Size & Share | Analysis - 2026
UPCOMING REPORT’S INTRODUCTION: According to an upcoming report of Allied Market Research, titled, “Ultrasonic Air Bubble Detectors Market”, the Ultrasonic Air Bubble Detectors market is expected to grow sustainably from 2020 to 2027. The report offers a comprehensive analysis of various growth drivers of the Ultrasonic Air Bubble Detectors market. The analysis ranges from revenue and operations to future growth opportunities. This comprehensive analysis of great importance for stakeholders to
World GPS Tracking Device Market - Opportunities and Forecasts, 2020-2027
Analyzing the current situation of pandemic, Allied market research has published a report t, which says, the GPS Tracking Device market is expected to grow at a faster pace by 2027. The researchers have intelligently made analysis and forecasts of the future growth by taking the past performance and data into consideration. The analysis offered by the report will surely provide valuable insights to the stakeholders of the GPS Tracking
Automotive Smart Helmet Market Statistics 2020: Advanced Technologies, Trends, C …
Allied Market Research published a new report, titled, "Automotive Smart Helmet Market." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. Get detailed COVID-19 impact
Hybrid Funds Market Size, Share and Growth | Analysis - 2027
INTRODUCTION TO REPORT The report published by Allied market research, titled, “Hybrid Funds Market”, offers a comprehensive analysis of key growth drivers, key segments, development strategies, market opportunities, and competitive landscape. This study offers detailed insights for market players, investors, stakeholders, and new entrants to understand the industry dynamics and determine strategic steps to gain the competitive advantage. COVID_19 Scenarios: The Hybrid Funds has been the worst hit by COVID-19 globally. Based
More Releases for Albumin
Global Serum Albumin Market Research Report
This report studies the global Serum Albumin market status and forecast, categorizes the global Serum Albumin market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Octapharma Kedrion CSL Behring Shire (Baxter) Grifols Hualan Bio Taibang Bio RAAS Greencross Geographically, this report studies
Global Glycated Albumin Market Growth 2019-2024
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy. Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose
Glycated Albumin Market
Market players and various research organisations are engaged in developing novel diagnostic tests using glycated albumin in order to meet increasing demand from end-use industries. For instance, in 2016, according to a study published in journal Nephrology Dialysis Transplantation reported that glycated albumin might provide a valuable alternative for predicting mortality in diabetic patients on hemodialysis. Furthermore, leading players in the market are focused on new product launches and its
Global Albumin Market $307 Million by 2021
According to a market research report Albumin Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc., the global albumin market is estimated to reach $307 Million in 2021, expanding at a CAGR of 2.4% from 2017 to 2021. The global albumin market segmentation is based on type (human serum albumin, bovine serum albumin, recombinant albumin), and its applications (drug formulation and drug delivery, vaccines, components of media). The global albumin market
Global Glycated Albumin Sales Market Report 2017
24 Market Reports provides a complete data analysis of Global Glycated Albumin Sales Market Report 2017 with Market value, Sales, Price, Industry Analysis and Forecast with the help of Industry Experts. In this report, the global Glycated Albumin market is expected to reach high by the end of 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Glycated
Latest market Research | Glycated Albumin Sales 2017
This report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Glycated Albumin for these regions, from 2012 to 2022 (forecast), covering • United States • China • Europe • Japan • Southeast Asia • India Global Glycated Albumin market competition by top manufacturers/players, with Glycated Albumin sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including • Asahi Kasei Pharma • DIAZYME • Abnova • LifeSpan • Exocell • BSBE • Medicalsystem • Maccura • Leadman • Simes Sikma • NINGBO PUREBIO On the basis of product, this